Royalty Report: Medical, Device, Diagnostic – Collection: 3394

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 12

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 12

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • Surgical
  • Catheter
  • cardiac

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 3394

License Grant
The Licensor granted the Company the exclusive world-wide rights to develop, make and sell the HCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.
License Property
The HCMS will provide the primary measures of cardiac performance and left atrial pressure which are crucial measurements in treating critically ill patients.

5,048,532-Method and Apparatus for Measuring Blood Pressure (S-409)
5,181,517-Method and Apparatus for the Measurement of Atrial Pressure (S-409)

IPSCIO Record ID: 6937

License Grant
The Licensor granted the Licensee the exclusive world-wide rights to develop, manufacture and distribute the SCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.
License Property
Tangible Property
1. One prototype two-balloon esophogeal catheter.
2. One prototype system control box.
3. One copy of Source Code.
4. One laptop with operational Source Code, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.
5. One Dynamap Blood Pressure Monitor, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.
6. One ECG device compatible with the system, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

5,048,532 U.S. Patent Method and Apparatus for Measuring Blood Pressure (S-409)

5,181,517 U.S. Continuation in Part Patent Method and Apparatus for the Measurement of Atrial Pressure (S-409)

5,263,485 U.S. Continuation in Part Patent Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409

6,120,442 U.S. Patent Method and Apparatus for Noninvasive Determination of Cardiac Performance Parameters (R-5421)

5,697,375 U.S. Continuation in Part Patent Method and Apparatus Utilizing Heart Sounds for Determining Pressure Associated with the Left Atrium (S-409)

IPSCIO Record ID: 26662

License Grant
Licensor grants to Licensee an exclusive license under its Technology rights to (a) develop, make, have made, use, sell and offer for sale or otherwise exploit the Licensed Products, and (b) use and reproduce Software, create Derivatives, and distribute Software to end-users through the normal channels of distribution, in the Field and Territory during the Term. Licensees will have the unrestricted right to develop Licensee Improvements relating to the Licensed Products in the United States for distribution and exploitation of the Licensed Products either in the United States or outside of the United States. Licensee will also have the unrestricted right to develop Licensee Improvements relating to the Licensed Products in any foreign country for distribution and exploitation of the Licensed Products in any other country, including the U.S.
License Property
Patents relate to develop, make and sell the HCMS, a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.

TANGIBLE PROPERTY
1.  One prototype two-balloon esophogeal catheter.

2.  One prototype system control box.

3.  One copy of Source Code.

4.  One laptop with operational Source Code, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

5.  One Dynamap Blood Pressure Monitor, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

6.  One ECG device compatible with the system, which will be returned to Licensor within ninety (90) days of the transfer, unless otherwise mutually agreed to by the parties.

PATENTS
5,048,532
U.S. Patent
Method and Apparatus for Measuring Blood Pressure (S-409)

5,181,517
U.S. Continuation in Part Patent
Method and Apparatus for the Measurement of Atrial Pressure (S-409)

PCT/US
Corresponds to U.S. 5,181,517
Method and Apparatus for the Measurement of Atrial Pressure (S-409)

91/04504

5,263,485
U.S. Continuation in Part Patent
Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409)

5,398,692
U.S. Continuation in Part Patent
Combination Esophageal Catheter for the Measurement of Atrial Pressure (S-409))

5,551,439
U.S. Continuation in Part Patent
Method of Determining a Mean Pressure from a Source within a Body (S-409)

5,570,671
U.S. Continuation in Part Patent
Method for Positioning Esophageal Catheter for Determining Pressures Associated with the Left Atrium (S-409)

5,697,375
U.S. Continuation in Part Patent
Method and Apparatus Utilizing Heart Sounds for Determining Pressure Associated with the Left Atrium (S-409)

5,921,935
U.S. Divisional Patent
Method and Apparatus for Utilizing Heart Sounds For Determining Pressures Associated with the Left Atrium (S-409)

PCT/US
Corresponds to U.S. ‘671, ‘375, ‘935
Method and Apparatus for Determining Pressures Associated with the Left Atrium (S-409)

96/17617

IPSCIO Record ID: 289542

License Grant
If, and only if, Licensor exercises its option for a license under the CIC Patents pursuant to this agreement, Licensor shall grant (and will cause its Affiliates to grant) to Licensee and its Affiliates the right and option until the expiration of thirty (30) months from the Effective Date or ninety (90) days from the date Licensor exercises its option, whichever is later in time, to obtain a non-exclusive, worldwide, non-transferable, royalty-bearing license under the Savacor Patents.
License Property
Savacor Patents shall mean those patents and patent applications, and all patents and patent applications claiming priority therefrom, that Licensor or its Affiliates acquired from Savacor, Ind. as set forth.  The Savacor Patents shall include the sublicensable patents and patent applications of Cedars Sinai Medical Center listed.

6,970,742 – Method for detecting, diagnosing, and treating cardiovascular disease
6,328,699 – Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure

Field of Use
“CRM Products” means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term “CRM Products” includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software. The term “CRM Products” excludes, by way of example and not limitation, nerve stimulators (unless used for cardiac therapy), bone growth stimulators, drug release pumps, cardiac pumps, artificial hearts, prosthetic heart valves, catheter ablation devices, imaging systems, catheter location systems, apparatus for revascularization or correction of other physical defects in heart tissue, arrhythmia mapping devices (except as part of an implantable cardiac therapy or monitoring device), angioplasty devices and EKG monitors (other than cardiac stimulation device programmers or other telemetry devices for use with implantable pulse generators or cardiac monitors) which are standalone, non-ambulatory and not intended for transtelephonic or other remote monitoring.

IPSCIO Record ID: 211915

License Grant
Licensor hereby grants to Licensee an exclusive, worldwide, right and license to practice the Patent Rights and Know-How in the Field of Use to make, have made, develop, improve, use, promote, market and sell Sensors and Instruments, including the right to have third parties manufacture, sell and distribute on behalf of Licensee.
License Property
The licensed property are such patents and applications relating to a method and device for taking measurements in the alimentary canal region between the stomach and the mouth, or in the respiratory canal region between the lungs and face, including mouth and nasal regions, to assess or help assess systemic hypoperfusion.

Sensor as used in this Agreement means any device which detects signals either in or around
(1) the alimentary canal between the stomach and the mouth;
(2) the mouth;
(3) the nasal passages; or
(4) the respiratory region between the lungs and face (nose/mouth), to assess or help assess systemic hypoperfusion and that is covered by a validly issued U.S. patent included in the Patent Rights. Sensors can be disposable or reusable, and shall not include any part of an Instrument, which may connect to the Sensor to process electrical or optical signals from the Sensor.

Field of Use
Field of Use means applications for taking measurements in the alimentary canal region between the stomach and the mouth, or in the respiratory canal region between the lungs and face (including mouth and nasal regions) to assess or help assess systemic hypoperfusion, and specifically excludes all Field Forward Military Applications and all other applications not directly related to taking measurements in the alimentary and respiratory regions referred to herein to assess or help assess systemic hypoperfusion (e.g., measurements for regional tissue perfusion of any internal organ, appendage, etc.).

IPSCIO Record ID: 6931

License Grant
During 2010 we had royalty agreements related to our AtriClip system, which is designed to safely and effectively exclude the left atrial appendage.
License Property
Our AtriClip system is designed to exclude the left atrial appendage by implanting the device during concomitant open surgical procedures from the outside of the heart, avoiding contact with the circulating blood pool while eliminating blood flow between the left atrial appendage and the atria. We believe that our AtriClip system is potentially safer, more effective and easier to use when permanently excluding the left atrial appendage than current products and techniques.
Field of Use
The rights granted apply to medical devices relating to the healthcare industry.

IPSCIO Record ID: 51408

License Grant
Pursuant to the License Agreement, the Licensor granted the company the exclusive world-wide rights to develop, manufacture and distribute the SCMS.  The License Agreement requires the company to use commercially reasonable efforts to develop and market the SCMS within certain timeframes, subject to specified exceptions.
License Property
Scivanta Cardiac Monitoring System (the SCMS), a minimally invasive two-balloon esophageal catheter system used to monitor cardiac performance.
Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 4800

License Grant
The Company an exclusive worldwide license under three issued U.S. patents, an exclusive license under one patent application pending in the European Patent Office and additional filed or licensed patent applications and continuations for the ALERT System with an undisclosed Licensee.
License Property
ALERT System is an atrial fibrillation which uses a patented electrode catheter to deliver measured, variable, low energy electrical impulses directly to the inside of the heart in order to convert atrial fibrillation to a normal heart rhythm.

IPSCIO Record ID: 25881

License Grant
The license covers a medical technology for the non invasive monitoring of blood pressure and blood flow that the Licensee intends to develop and commercialize.
License Property
The HEARTSTAT TECHNOLOGY AND RELATED ASSETS which is a medical technology for the non invasive monitoring of blood pressure and blood flow that Licensee intends to develop and commercialize.

IPSCIO Record ID: 27887

License Grant
The Licensee holds an exclusive worldwide License to use, manufacture and sell products covered by the Metricath patent.
License Property
The Metricath System is a catheter-based technology that allows cardiologists to measure arterial size and wall characteristics, select stent and other treatment devices and confirm stent deployment during interventional treatment of coronary and peripheral artery disease.

IPSCIO Record ID: 257712

License Grant
The Licensee is obligated under the License Agreement to pay a royalty on the net sales of its  dual  use uterine monitoring catheter, AmCath,  to the Inventors, two individuals.
License Property
The dual use uterine monitoring catheter, AmCath, that allows simultaneous measurement of interuterine pressure during labor and a means for administering sterile isotonic solution.
Field of Use
The Licensee strives to develop new products in the areas of the medical device industry.

IPSCIO Record ID: 4805

License Grant
The Company obtained from Licensor, an individual, a non-exclusive license under an issued U.S. patent for the ALERT® System including the ALERT® Companion and ALERT® internal cardioversion catheters and related disposable supplies like unique one-piece catheter.
License Property
The ALERT® System uses a patented electrode catheter to deliver measured, variable, low-energy bi-phasic electrical impulses directly to the inside of the heart to convert atrial fibrillation to a normal heart rhythm.  The ALERT® Companion is synchronization of a defibrillation shock delivered.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.